Funds managed by Harvest Fund Management Co., Ltd. have increased their holdings of CSPC PHARMA (01093) by 5.656 million shares, at a price of approximately HK$8.29 per share.
On July 6th, E Fund Management Co., Ltd. increased its holdings of China Resources Pharmaceutical Group (01093) by 5,656,000 shares, with a price of 8.2902 Hong Kong dollars per share, for a total amount of approximately 46.8894 million Hong Kong dollars.
The latest data from the Hong Kong Stock Exchange shows that on July 6th, the Hang Seng Fund Management Co., Ltd. increased its holding of CSPC PHARMA (01093) by 5.656 million shares, with a price of 8.2902 Hong Kong dollars per share, totaling approximately 46.8894 million Hong Kong dollars. After the increase, the new total number of shares held is approximately 577 million, with a shareholding percentage of 5%.
Related Articles
BOC International: The conditions for the hard technology sector in A-shares to transition from an oversold recovery to a trending market are accelerating in maturity.
Chen Guo: The non-bank financial sector is currently significantly undervalued.
PRIME INTEL (08379): Wang Yicheng appointed as the authorized representative
BOC International: The conditions for the hard technology sector in A-shares to transition from an oversold recovery to a trending market are accelerating in maturity.
Chen Guo: The non-bank financial sector is currently significantly undervalued.
PRIME INTEL (08379): Wang Yicheng appointed as the authorized representative
RECOMMEND
